Charles Rhyee
Stock Analyst at TD Cowen
(1.47)
# 3,846
Out of 5,048 analysts
61
Total ratings
38.46%
Success rate
-9.3%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $99 → $100 | $77.85 | +28.45% | 1 | Nov 3, 2025 | |
| CAH Cardinal Health | Maintains: Buy | $183 → $225 | $194.88 | +15.46% | 3 | Nov 3, 2025 | |
| OPCH Option Care Health | Maintains: Hold | $30 → $27 | $27.30 | -1.10% | 2 | Nov 3, 2025 | |
| IQV IQVIA Holdings | Downgrades: Hold | $206 → $215 | $212.66 | +1.10% | 2 | Nov 3, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Hold | $183 → $172 | $164.53 | +4.54% | 5 | Oct 24, 2025 | |
| MEDP Medpace Holdings | Maintains: Sell | $356 → $462 | $593.44 | -22.15% | 6 | Oct 24, 2025 | |
| VEEV Veeva Systems | Upgrades: Buy | $297 → $380 | $291.04 | +30.57% | 4 | Oct 7, 2025 | |
| MCK McKesson | Maintains: Buy | $830 → $864 | $841.02 | +2.73% | 4 | Sep 24, 2025 | |
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $178.20 | +27.38% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $9.68 | +158.40% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9 → $8 | $7.92 | +1.01% | 6 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $3.26 | +390.80% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $5 | $3.34 | +49.70% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $100 → $50 | $5.12 | +876.56% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $8.48 | +560.38% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $360 → $280 | $13.47 | +1,978.69% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $6.59 | +658.73% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $28.16 | +24.31% | 1 | Feb 13, 2018 |
CVS Health
Nov 3, 2025
Maintains: Buy
Price Target: $99 → $100
Current: $77.85
Upside: +28.45%
Cardinal Health
Nov 3, 2025
Maintains: Buy
Price Target: $183 → $225
Current: $194.88
Upside: +15.46%
Option Care Health
Nov 3, 2025
Maintains: Hold
Price Target: $30 → $27
Current: $27.30
Upside: -1.10%
IQVIA Holdings
Nov 3, 2025
Downgrades: Hold
Price Target: $206 → $215
Current: $212.66
Upside: +1.10%
ICON Public Limited Company
Oct 24, 2025
Maintains: Hold
Price Target: $183 → $172
Current: $164.53
Upside: +4.54%
Medpace Holdings
Oct 24, 2025
Maintains: Sell
Price Target: $356 → $462
Current: $593.44
Upside: -22.15%
Veeva Systems
Oct 7, 2025
Upgrades: Buy
Price Target: $297 → $380
Current: $291.04
Upside: +30.57%
McKesson
Sep 24, 2025
Maintains: Buy
Price Target: $830 → $864
Current: $841.02
Upside: +2.73%
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $178.20
Upside: +27.38%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $9.68
Upside: +158.40%
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $7.92
Upside: +1.01%
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $3.26
Upside: +390.80%
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $3.34
Upside: +49.70%
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $5.12
Upside: +876.56%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $8.48
Upside: +560.38%
Aug 16, 2022
Maintains: Outperform
Price Target: $360 → $280
Current: $13.47
Upside: +1,978.69%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $6.59
Upside: +658.73%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $28.16
Upside: +24.31%